Morgan Stanley Immutep LTD Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Immutep LTD stock. As of the latest transaction made, Morgan Stanley holds 165,966 shares of IMMP stock, worth $308,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares

165,966

Previous 119,466 38.92%

Holding current value

$308,696

Previous $195,000 52.82%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.61 - $1.8 $74,865 - $83,700	46,500 Added 38.92%	165,966 $298,000
Q2 2025 Aug 15, 2025	BUY	$1.41 - $2.49 $148,317 - $261,923	105,190 Added 736.83%	119,466 $195,000
Q1 2025 May 15, 2025	SELL	$1.7 - $2.21 $26,032 - $33,841	-15,313 Reduced 51.75%	14,276 $25,000
Q4 2024 Feb 14, 2025	BUY	$1.82 - $2.36 $26,411 - $34,248	14,512 Added 96.25%	29,589 $64,000
Q3 2024 May 14, 2025	SELL	$1.77 - $2.64 $159,696 - $238,191	-90,224 Reduced 85.68%	15,077 $33,000
Q3 2024 Nov 14, 2024	SELL	$1.77 - $2.64 $159,696 - $238,191	-90,224 Reduced 85.68%	15,077 $33,000
Q2 2024 May 14, 2025	BUY	$1.87 - $3.23 $141,581 - $244,549	75,712 Added 255.88%	105,301 $211,000
Q2 2024 Oct 17, 2024	BUY	$1.87 - $3.23 $148,292 - $256,142	79,301 Added 305.0%	105,301 $211,000
Q2 2024 Aug 14, 2024	BUY	$1.87 - $3.23 $148,292 - $256,142	79,301 Added 305.0%	105,301 $211,000
Q1 2024 Oct 17, 2024	SELL	$2.11 - $2.89 $167,325 - $229,179	-79,301 Reduced 75.31%	26,000 $60,000
Q1 2024 Aug 16, 2024	BUY	$2.11 - $2.89 $5,277 - $7,227	2,501 Added 10.64%	26,000 $60,000
Q1 2024 May 15, 2024	BUY	$2.11 - $2.89 $5,277 - $7,227	2,501 Added 10.64%	26,000 $60,000
Q4 2023 Aug 16, 2024	SELL	$1.76 - $2.49 $143,971 - $203,686	-81,802 Reduced 77.68%	23,499 $56,000
Q4 2023 Feb 13, 2024	BUY	$1.76 - $2.49 $1,240 - $1,755	705 Added 3.09%	23,499 $56,000
Q3 2023 Nov 15, 2023	BUY	$1.75 - $2.37 $525 - $711	300 Added 1.33%	22,794 $43,000
Q2 2023 Aug 14, 2023	SELL	$1.54 - $2.62 $915,169 - $1.56 Million	-594,266 Reduced 96.35%	22,494 $47,000
Q1 2023 May 15, 2023	BUY	$1.63 - $2.06 $164,033 - $207,306	100,634 Added 19.5%	616,760 $1.04 Million
Q4 2022 Feb 14, 2023	SELL	$1.6 - $2.53 $331,750 - $524,580	-207,344 Reduced 28.66%	516,126 $903,000
Q3 2022 Nov 14, 2022	SELL	$1.56 - $2.29 $58,568 - $85,975	-37,544 Reduced 4.93%	723,470 $1.13 Million
Q2 2022 Oct 27, 2022	SELL	$1.96 - $3.09 $542,155 - $854,724	-276,610 Reduced 26.66%	761,014 $1.55 Million
Q2 2022 Aug 15, 2022	SELL	$1.96 - $3.09 $542,155 - $854,724	-276,610 Reduced 26.66%	761,014 $1.55 Million
Q1 2022 Oct 27, 2022	BUY	$2.3 - $3.61 $636,203 - $998,562	276,610 Added 36.35%	1,037,624 $2.84 Million
Q1 2022 May 13, 2022	BUY	$2.3 - $3.61 $127,212 - $199,669	55,310 Added 5.63%	1,037,624 $2.84 Million
Q4 2021 Feb 14, 2022	SELL	$3.09 - $4.81 $828,580 - $1.29 Million	-268,149 Reduced 21.44%	982,314 $3.22 Million
Q3 2021 Nov 15, 2021	BUY	$3.17 - $4.39 $3.96 Million - $5.49 Million	1,250,463 New	1,250,463 $4.84 Million

Others Institutions Holding IMMP

# of Institutions

Shares Held

2.35M

Call Options Held

1.28K

Put Options Held

20K

View Full List

About IMMUTEP Ltd

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $161M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

More about IMMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account